Table 2:

Hazard ratios and 95% confidence intervals for selected variables showing association with 60-day and overall survival

Variable	Hazard ratio for 60-day survival (95% confidence interval)	P	Hazard ratio for overall survival (95% confidence interval)	P
Patient characteristics at ICU entry
Age (above vs. below median)	0.83 (0.25, 2.71)	0.75	0.89 (0.42, 1.89)	0.76
CD4 count (<100 vs. ≥100)	1.35 (0.41, 4.42)	0.62	0.77 (0.34, 1.72)	0.52
HIV VL (<25 vs. ≥25)	0.37 (0.10, 1.39)	0.14	1.00 (0.47, 2.15)	0.99
SOFA score (<6 vs. ≥6)	1.73 (0.51, 5.91)	0.38	1.43 (0.66, 3.09)	0.37
KSHV VL (above vs. below median)	1.82 (0.48, 6.89)	0.37	1.44 (0.66, 3.16)	0.37
KAD diagnoses at ICU discharge or death
MCD +/− KS	0.28 (0.04, 2.15)	0.21	0.59 (0.22, 1.57)	0.29
KICS +/− KS	0.82 (0.22, 3.09)	0.77	1.35 (0.59, 3.08)	0.47
PEL +/− MCD +/− KS	3.37 (0.99, 11.55)	0.05	2.03 (0.95, 4.35)	0.07
ICU Interventions
Vasopressors	3.25 (0.86, 12.25)	0.08	2.23 (1.02, 4.88)	0.05
Mechanical ventilation	4.95 (1.44, 16.96)	0.01	2.99 (1.29, 6.97)	0.01
Chemotherapy or other for KAD	3.22 (0.85, 12.14)	0.85	1.54 (0.71, 3.32)	0.27
Cytokines at admission to ICU – (above vs. below median)
Interferon-γ, pg/mL	1.29 (0.34, 4.85)	0.71	1.65 (0.68, 4.02)	0.27
IL-10, pg/mL	1.33 (0.35, 5.03)	0.67	1.14 (0.51, 2.56)	0.75
IL-12, pg/mL	0.82 (0.24, 2.82)	0.76	1.06 (0.47, 2.37)	0.90
IL-13, pg/mL	0.40 (0.12, 1.32)	0.13	0.67 (0.31, 1.43)	0.30
IL-1β, pg/mL	0.65 (0.20, 2.12)	0.47	0.77 (0.36, 1.71)	0.54
IL-2, pg/mL*	1 (NA)	NA	1 (NA)	NA
IL-4, pg/mL	1.30 (0.35, 4.91)	0.70	1.43 (0.62, 3.28)	0.40
IL-6, pg/mL	1.33 (0.35, 5.03)	0.67	1.79 (0.76, 4.22)	0.19
IL-8, pg/mL	0.71 (0.21, 2.41)	0.58	0.54 (0.25, 1.15)	0.11
TNF-α, pg/mL	0.74 (0.22, 2.53)	0.63	0.84 (0.38, 1.85)	0.66

^*No values below median